Logo-ijhpm
Int J Health Policy Manag. 2021;10(8): 495-499. doi: 10.34172/ijhpm.2020.100
PMID: 32610816        PMCID: PMC9056197

Short Communication

Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort Study

Joel Lexchin 1,2,3 * ORCID

Cited by CrossRef:

1- Lexchin J. Time to market for drugs approved in Canada between 2014 and 2018: an observational study. BMJ Open. 2021;11(7):e047557 [Crossref]
2- Beall R, Kesselheim A, Hollis A. Premarket Development Times for Innovative Vaccines––To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers?. 2022;74(2):347 [Crossref]
3- Maravilla V, Pelmin M. Shared Governance in Community-Oriented Tourist Destinations: An Exploratory Case Study. JIP. 2025;3(5) [Crossref]